ArticleOncotarget2017

Urokinase-type plasminogen activator receptor inhibits apoptosis in triple-negative breast cancer through miR-17/20a suppression of death receptors 4 and 5.

Xin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.